sj-docx-1-smo-10.1177_20503121221140231 – Supplemental material for Neutrophil–lymphocyte ratio as an inflammatory biomarker of diabetic nephropathy among type 2 diabetes mellitus patients: A comparative cross-sectional study

Supplemental material, sj-docx-1-smo-10.1177_20503121221140231 for Neutrophil–lymphocyte ratio as an inflammatory biomarker of diabetic nephropathy among type 2 diabetes mellitus patients: A comparative cross-sectional study by Mesfin Zewude Gurmu, Solomon Genet, Solomon Tebeje Gizaw, Teka Obsa Feyisa and Netasan Gnanasekaran in SAGE Open Medicine</p

Laboratory biomarker-related variables by COVID severity classification (n = 126).

Laboratory biomarker-related variables by COVID severity classification (n = 126).</p

Co-morbidity among COVID-19 patients admitted to the hospital.

CVD, Cardiovascular disease, COPD, Chronic obstructive pulmonary disease, DM, Diabetes Mellitus, HTN, Hypertension.</p

S1 Data -

(SAV)</p

Fig 3 -

ROC curve analysis to predict creatinine as predictor of disease severity (A) and mortality (B).</p

Demographics characteristic of COVID-19 patients.

Demographics characteristic of COVID-19 patients.</p

Demographic, clinical and laboratory profiles by survivorships status.

Demographic, clinical and laboratory profiles by survivorships status.</p

Association of sociodemographic features, clinical history, laboratory profile with severity and mortality among COVID-19 patients (n = 126).

Association of sociodemographic features, clinical history, laboratory profile with severity and mortality among COVID-19 patients (n = 126).</p

Fig 2 -

ROC curve analysis to predict NLR as predictor of disease severity (A) and mortality (B).</p

Creatinine and NLR as predictor of disease severity and mortality of COVID-19.

Creatinine and NLR as predictor of disease severity and mortality of COVID-19.</p